Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States

Abstract Introduction In the post-pandemic era, people with underlying medical conditions continue to be at increased risk for severe COVID-19 disease, yet COVID-19 vaccination uptake remains low. This study estimated the clinical and economic impact of updated 2023/24 Moderna COVID-19 vaccination a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Keya Joshi, Mariia Dronova, Ewelina Paterak, Van H. Nguyen, Hagit Kopel, James Mansi, Nicolas Van de Velde, Ekkehard Beck
Format:	Artigo
Idioma:	Inglês
Publicat:	Adis, Springer Healthcare 2025-04-01
Col·lecció:	Infectious Diseases and Therapy
Matèries:	Cardiovascular disease Chronic kidney disease Chronic lung disease COVID-19 Diabetes Immunocompromised
Accés en línia:	https://doi.org/10.1007/s40121-025-01128-z
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!